Valproic Acid Prenatal Exposure
- 1 February 1989
- journal article
- case report
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 28 (2), 81-85
- https://doi.org/10.1177/000992288902800205
Abstract
Valproic acid is an anticonvulsant that has been associated with open neural tube defects. We report a family in which the maternal use of valproic acid, and other anticonvulsants, during pregnancy resulted in different malformations in two siblings, one of which had a lipomyelomeningocele. The association of valproic acid and closed neural tube defects has not previously been reported. A brief review of the teratogenic effects of valproic acid is included as well as the implications for early surgical management of lipomyelorneningocele.Keywords
This publication has 13 references indexed in Scilit:
- Verification of the fetal valproate syndrome phenotypeAmerican Journal of Medical Genetics, 1988
- IN-UTERO EXPOSURE TO VALPROATE AND NEURAL TUBE DEFECTSThe Lancet, 1986
- Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acidThe Journal of Pediatrics, 1986
- GENETIC PREDISPOSITION TO PHENYTOIN-INDUCED BIRTH DEFECTSThe Lancet, 1985
- Management of lipomyelomeningocelesJournal of Neurosurgery, 1985
- The fetal valproate syndromeAmerican Journal of Medical Genetics, 1984
- FURTHER EXPERIENCE OF VITAMIN SUPPLEMENTATION FOR PREVENTION OF NEURAL TUBE DEFECT RECURRENCESThe Lancet, 1983
- Fetal Drug Syndromes: Effects of Ethanol and HydantoinsPediatrics in Review, 1979
- Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndromeThe Journal of Pediatrics, 1976
- The fetal hydantoin syndromeThe Journal of Pediatrics, 1975